PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)

SHE:300725 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	332.31	290.2	511.19	1,150	699.63	1,245
Short-Term Investments	937.17	618.48	984.26	303.46	100.74	25
Trading Asset Securities	396.23	465.61	105.35	163.3	304.43	107.62
Cash & Short-Term Investments	1,666	1,374	1,601	1,617	1,105	1,377
Cash Growth	34.80%	-14.15%	-1.01%	46.38%	-19.79%	511.93%
Accounts Receivable	301.39	483.69	473.66	330.61	201.27	167.08
Other Receivables	2.73	1.92	2.62	1.83	2.11	1.31
Receivables	304.12	485.61	476.28	332.44	203.38	168.39
Inventory	723.55	840.17	724.79	676.39	447.94	309.63
Other Current Assets	7.31	16.88	15.88	33.8	47.89	17.77
Total Current Assets	2,701	2,717	2,818	2,660	1,804	1,873
Property, Plant & Equipment	1,650	1,684	1,753	1,661	1,173	309.36
Long-Term Investments	649.63	19.86	5.48	5.66	8.91	156.97
Goodwill	355.74	355.74	356.19	356.19	356.19	31.2
Other Intangible Assets	105.24	107.98	109.42	111.48	111.47	33.83
Long-Term Deferred Tax Assets	35.83	32.63	38.61	35.8	15.1	11.66
Long-Term Deferred Charges	6.55	6.94	10.14	9.18	7.24	2.35
Other Long-Term Assets	20.3	10.99	13.1	22.8	30.74	6.71
Total Assets	5,524	4,935	5,104	4,862	3,507	2,425
Accounts Payable	245.42	292.2	278.7	413.47	267.35	183.68
Accrued Expenses	73.28	91	104.71	88.18	60.61	30.72
Short-Term Debt	230.18	230.27	236.5	163.4	347.64	120.44
Current Portion of Long-Term Debt	2.93	52.74	371.43	17.29	7.95	-
Current Portion of Leases	1.39	1.26	1.99	-	1.82	-
Current Income Taxes Payable	9.3	16.96	15.7	0.85	0.15	10.84
Current Unearned Revenue	114.19	56.28	32.73	39.63	28.7	57.32
Other Current Liabilities	6.96	8.53	14.33	16.35	74.66	72.94
Total Current Liabilities	683.66	749.23	1,056	739.18	788.88	475.94
Long-Term Debt	1,145	1,127	1,138	1,392	23.6	-
Long-Term Leases	3.15	3.21	0.23	-	-	-
Long-Term Unearned Revenue	45.28	46.61	52.64	52.85	54.14	53.63
Long-Term Deferred Tax Liabilities	20.58	22.13	24.31	20.15	12.58	1
Total Liabilities	1,898	1,948	2,272	2,205	879.21	530.57
Common Stock	199.73	199.73	199.66	199.66	199.7	153.62
Additional Paid-In Capital	1,097	1,096	1,090	1,075	1,299	1,313
Retained Earnings	1,613	1,597	1,439	1,261	967.1	495.91
Treasury Stock	-30.04	-30.04	-20.03	-	-35	-64.58
Comprehensive Income & Other	745.87	125.24	123.52	121.74	-3.44	-3.13
Total Common Equity	3,626	2,988	2,832	2,658	2,427	1,895
Minority Interest	-	-	-	0	200.29	0
Shareholders' Equity	3,626	2,988	2,832	2,658	2,628	1,895
Total Liabilities & Equity	5,524	4,935	5,104	4,862	3,507	2,425
Total Debt	1,383	1,414	1,749	1,573	381.02	120.44
Net Cash (Debt)	282.8	-39.71	-147.83	44.11	723.78	1,257
Net Cash Growth	-	-	-	-93.91%	-42.42%	663.04%
Net Cash Per Share	1.40	-0.20	-0.73	0.22	3.63	6.69
Filing Date Shares Outstanding	203.93	198.89	198.83	199.66	199.7	199.7
Total Common Shares Outstanding	203.93	198.89	198.83	199.66	199.7	199.7
Working Capital	2,017	1,968	1,762	1,921	1,015	1,397
Book Value Per Share	17.78	15.02	14.24	13.31	12.16	9.49
Tangible Book Value	3,165	2,524	2,367	2,190	1,960	1,830
Tangible Book Value Per Share	15.52	12.69	11.90	10.97	9.81	9.16
Buildings	949.07	950.4	905.31	844.6	344.88	81.95
Machinery	1,252	1,052	1,025	792.72	510.13	151.75
Construction In Progress	58.97	232.68	256.23	357.53	575.32	171.25

Source: S&P Global Market Intelligence. Standard template. Financial Sources.